Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

2024197 citationsJournal Articlegold Open Access

Authors

For the Portuguese, Spanish translations and plain language summary of the abstract see Supplementary Materials section.

Good health and well-being

Published in: The Lancet Global Health

Volume 12, Issue 2, pp. e257-e270

Field-Weighted Citation Impact: 106.02